(NASDAQ:ACLX) engages in the development of various immunotherapies for patients with cancer and other incurable diseases.

Daratumumab plus VRd significantly improves survival in newly diagnosed multiple myeloma, supporting its role as a new ...

A Cavan woman battling a rare and incurable form of bone marrow cancer hopes to run her 600th lifetime marathon by June of ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

The double-headed antibody binds to CD3 on T cells and redirects them to BCMA-expressing myeloma cells, with the aim of stimulating an immune attack on the tumour, which remains incurable despite ...

The FDA has approved Bristol-Myers Squibb’s Abecma (idecabtagene vicleucel) for multiple myeloma, the first cell ... forward in the treatment of this incurable condition. It is a CAR-T (chimeric ...

"Find joy in all circumstances," the late David Bauer said, quoting Apostle Paul in the Bible. He did that even as he fought multiple myeloma for five years.

Hong Kong Department of Health accepts IASO Bio’s NDA for equecabtagene autoleucel to treat r/r multiple myeloma: Shanghai, Nanjing Monday, February 17, 2025, 17:00 Hrs [IST] IA ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

Karen Wilde knows from her own perspective how important it is to that Myeloma Australia receives financial support and that's why she's thrilled that the racing industry will again be to the fore ...

In a heartfelt moment of sorrow, Prince William finds himself mourning the loss of one of his closest friends, Zach Stubbings ...